Mortality Risk Stratification by Combining <i>BRAF </i>V600E and <i>TERT</i> Promoter Mutations in Papillary Thyroid Cancer

DOI PDF 8 Citations
  • Rengyun Liu
    Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Justin Bishop
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Guangwu Zhu
    Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Tao Zhang
    Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Paul W. Ladenson
    Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Mingzhao Xing
    Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Bibliographic Information

Other Title
  • Genetic Duet of <i>BRAF</i> and <i>TERT</i> Promoter Mutations in Thyroid Cancer Mortality

Journal

  • JAMA Oncology

    JAMA Oncology 3 (2), 202-, 2017-02-01

    American Medical Association (AMA)

Citations (8)*help

See more

Report a problem

Back to top